Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|February 21, 2017
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's DiseaseGeorgia Watt, Tim Karl
Behavioural Brain Research|August 28, 2023
Light phase does not affect operant sucrose self-administration in adult male C57BL/6JAbr miceGeorgia Watt, Tim Karl, Rose Chesworth
Frontiers in Pharmacology|January 11, 2021
Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP /PS1ΔE9 Transgenic Female MiceMadilyn Coles, Georgia Watt, Fabian Kreilaus, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2026
Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibilityRose Chesworth, Georgia Watt, Erin McLemon, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic APPSwe/PS1∆E9 MiceGeorgia Watt, Juan Olaya, Gerald Muench, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 25, 2026
Persistent morphine memory during abstinence in female, but not male, metabotropic glutamate 5 receptor knockout miceErin McLemon, Georgia Watt, Rossana Rosa Porto, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 22, 2024
Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL/6JArc miceRose Chesworth, Howard Chi-Ho Yim, Georgia Watt, et al.
Behavioural Brain Research|October 5, 2020
The behavioural phenotype of 14-month-old female TAU58/2 transgenic miceFabian Kreilaus, Rebecca Masanetz, Georgia Watt, et al.
Pageof 2